The Federal Trade Commission will work with international regulators to review the effects of pharma mergers and update approaches to analysing them.
List view / Grid view
US Federal Trade Commission (FTC)
AbbVie and Allergan have announced the Federal Trade Commission has accepted AbbVie's pending acquisition of Allergan for $63 billion.
The US FDA will now approve biosimilars via a new regulatory pathway to help grow the competition between biologic products.
The two agencies have signed a statement of their intent to combat anti-competitive practices which are preventing the adoption of biosimilars in the US drug market.
A business selling unapproved products containing CBD has been sent a warning letter from the FDA and FTC for making unsubstantiated claims about their therapeutic properties.